Clinical Trial Update: Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer [NA]

View source ↗

Summary

This completed trial compared low-dose weekly docetaxel versus pemetrexed in previously treated advanced non-small cell lung cancer. The study has completed enr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Taxotere (docetaxel)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Non Small Cell Lung Cancer | NA | Status: COMPLETED